"De-escalation" strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany

"De-escalation" strategy using micafungin for the treatment of systemic Candida infections: budget impact in France and Germany

Anke van Engen,1 Montserrat Casamayor,2 Soyoung Kim,3 Maureen Watt,4 Isaac Odeyemi4 1Quintiles Consulting, Hoofddorp, the Netherlands; 2Quintiles Consulting, Barcelona, Spain; 3Astellas Pharma Singapore Pte., Singapore; 4Astellas Pharma Inc., Chertsey, UK Background: The incidence of azole-resistant...

Full description

Bibliographic Details
Main Authors: van Engen A, Casamayor M, Kim S, Watt M, Odeyemi I
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Candida
De-escalation
Fluconazole
Micafungin
Online Access:https://www.dovepress.com/de-escalation-strategy-using-micafungin-for-the-treatment-of-systemic--peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/de-escalation-strategy-using-micafungin-for-the-treatment-of-systemic--peer-reviewed-article-CEOR

Similar Items